The L-enantiomers of D-sugar-mimicking iminosugars are noncompetitive inhibitors of D-glycohydrolase?

被引:93
作者
Asano, N [1 ]
Ikeda, K
Yu, L
Kato, A
Takebayashi, K
Adachi, I
Kato, I
Ouchi, H
Takahata, H
Fleet, GWJ
机构
[1] Hokuriku Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9201181, Japan
[2] Toyama Med & Pharmaceut Univ, Dept Hosp Pharm, Toyama 9300194, Japan
[3] Yanaihara Inst Inc, Fujinomiya, Shizuoka 4180011, Japan
[4] Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9818558, Japan
[5] Univ Oxford, Dept Organ Chem, Cent Chem Lab, Oxford OX1 3TA, England
关键词
D O I
10.1016/j.tetasy.2004.11.067
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
1,4-Dideoxy-1,4-imino-L-arabinitol (L-AB1) and 2,5-dideoxy-2,5-imino-L-mannitol (L-DMDP) are much more potent inhibitors of isomaltase than their D-enantiomers. D-Enantiomers inhibited isomaltase in a competitive manner. whereas L-enantiomers were noncompetitive inhibitors of the enzyme. Similarly D-isofagomine and L-isofagomine were competitive and noncompetitive inhibitors of human lysosomal beta-D-glucosidase (beta-glucocerebrosidase), with K-i values of 0.016 and 5.7 muM, respectively. The multiple inhibition analysis of beta-glucocerebrosidase by D-isofagomine and L-isofagomine indicated that the D-enantiomer best fits the catalysis site of beta-glucocerebrosidase. while the L-enantiomer has a favorable interaction with a regulatory site other than the active site. Our recent and present results suggest that D-iminosugars are competitive inhibitors Of D-glycohydrolases but their L-enantiomers are noncompetitive inhibitors. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 30 条
[1]   Glycosidase inhibitors: update and perspectives on practical use [J].
Asano, N .
GLYCOBIOLOGY, 2003, 13 (10) :93R-104R
[2]   Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application [J].
Asano, N ;
Nash, RJ ;
Molyneux, RJ ;
Fleet, GWJ .
TETRAHEDRON-ASYMMETRY, 2000, 11 (08) :1645-1680
[3]   NITROGEN-IN-THE-RING PYRANOSES AND FURANOSES - STRUCTURAL BASIS OF INHIBITION OF MAMMALIAN GLYCOSIDASES [J].
ASANO, N ;
OSEKI, K ;
KIZU, H ;
MATSUI, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (22) :3701-3706
[4]   Polyhydroxylated pyrrolidine and piperidine alkaloids from Adenophora triphylla var. japonica (Campanulaceae) [J].
Asano, N ;
Nishida, M ;
Miyauchi, M ;
Ikeda, K ;
Yamamoto, M ;
Kizu, H ;
Kameda, Y ;
Watson, AA ;
Nash, RJ ;
Fleet, GWJ .
PHYTOCHEMISTRY, 2000, 53 (03) :379-382
[5]  
ASANO N, 2001, GLYCOSCIENCE CHEM CH, V3, P2541
[6]   Inhibition of glycosphingolipid biosynthesis: Application to lysosomal storage disorders [J].
Butters, TD ;
Dwek, RA ;
Platt, FM .
CHEMICAL REVIEWS, 2000, 100 (12) :4683-+
[7]   Therapeutic approaches to protein-misfolding diseases [J].
Cohen, FE ;
Kelly, JW .
NATURE, 2003, 426 (6968) :905-909
[8]   Evaluation of isofagomine and its derivatives as potent glycosidase inhibitors [J].
Dong, WL ;
Jespersen, T ;
Bols, M ;
Skrydstrup, T ;
Sierks, MR .
BIOCHEMISTRY, 1996, 35 (08) :2788-2795
[9]   A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity [J].
Fan, JQ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (07) :355-360
[10]   SYNTHESIS FROM D-GLUCOSE OF 1,5-DIDEOXY-1,5-IMINO-L-FUCITOL, A POTENT ALPHA-L-FUCOSIDASE INHIBITOR [J].
FLEET, GWJ ;
SHAW, AN ;
EVANS, SV ;
EVANS, SV .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1985, (13) :841-842